Journal Article (Letter)

DKFZ-2025-01738

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients.

Bröckelmann, P. J. ; Böll, B. ; Molin, D. ; Schneider, G. ; Leppä, S. ; Meissner, J. ; Kamper, P. ; Hutchings, M. ; Christensen, J. H. ; Schnetzke, U. ; Fuchs, M. ; Jablonski, J. ; Eichenauer, D. A. ; von Tresckow, B.DKFZ* ; Klapper, W. ; Kobe, C. ; Borchmann, P. ; Fosså, A.

2025
John Wiley & Sons Ltd. Hoboken

This record in other databases:  

Please use a persistent id in citations: doi:10.1002/hem3.70190

---

Contributing Institute(s):

1. DKTK Koordinierungsstelle Essen/Düsseldorf (ED01)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2025

---

Database coverage:
; ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Wiley ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---